Brief: Soligenix Provides Regulatory Update On Hybryte

Soligenix

14/04/2023 12:37

April 14 (Reuters) - Soligenix Inc  SNGX.O :
    * SOLIGENIX PROVIDES REGULATORY UPDATE ON HYBRYTE™
    * SOLIGENIX INC - CONVENED TYPE A MEETING WITH UNITED STATES
FDA
    * SOLIGENIX: CO'S REPRESENTATIVES, FDA DISCUSSED CONTENTS OF
A
REFUSAL TO FILE LETTER PREVIOUSLY ISSUED BY FDA ON CO'S NEW DRUG
APPLICATION FOR HYBRYTE
    * SOLIGENIX INC - FDA INDICATED THAT IT IS OPEN TO ENGAGING
IN
PROTOCOL DISCUSSIONS REGARDING SECOND CLINICAL STUDY FOR HYBRYTE

Source text for Eikon:  ID:nPn78Dhmqa 
Further company coverage:  SNGX.O 

 ((Reuters.Briefs@thomsonreuters.com;))